摘要
目的比较安列克与欣母沛在治疗与预防产后出血的疗效。方法收集在该院分娩、并有宫缩乏力或产后出血的高危因素单胎产妇243例,其中顺产120例,剖宫产123例。将顺产120例孕妇随机分为2组,A组60例使用安列克、A1组60例使用欣母沛。将剖宫产123例孕妇也随机分为2组,B组其中63例使用安列克、B1组60例使用欣母沛。分别观察顺产产后及剖宫产产后使用两种药物后的疗效,以及顺产组的药物不良反应。结果在剖宫产和顺产的产妇中,使用安列克和使用欣母沛的组间出血量均无明显差异,且年龄、孕次、孕周、新生儿体重、高危因素等方面均无统计学差异(P>0.05);两种药物的不良反应无统计学差异(P>0.05)。结论安列克是强效的子宫收缩剂,在防治产后出血方面与欣母沛有相同的疗效,且价格明显低于欣母沛。
Objective To compare the curative effects of Anlieke and Hemabate in treatment and prevention of postpartum hemorrhage.Methods A total of 243 women of single pregnancy who gave birth to their babies in the hospital and had high risk factors of uterine inertia and postpartum hemorrhage were collected,including 120 cases of natural delivery and 123 cases of cesarean section. One hundred and twenty cases of natural delivery were randomly divided into group A（ Anlieke） and group A1（ Hemabate）,60 cases in each group. One hundred and twenty-three cases of cesarean section were randomly divided into group B（ Anlieke,63 cases） and group B1（ Hemabate,60 cases）.The curative effects in natural delivery group and cesarean section group,the adverse reactions in natural delivery group were observed respectively. Results In natural delivery group and cesarean section group,there was no statistically significant difference in the amount of hemorrhage,age,gravidity,gestational week,neonatal weight,high risk factors,and adverse reactions between Anlieke subgroups and Hemabate subgroups（ P〉0. 05）. Conclusion Anlieke is a powerful uterotonic drug,which has the same effect as Hemabate in prevention and treatment of postpartum hemorrhage and has cheaper price compared with Hemabate.
出处
《中国妇幼保健》
CAS
2016年第20期4128-4130,共3页
Maternal and Child Health Care of China
